Author contribution: Xiaonian Lu and Juan Du are joint first authors of this study.
1346-8138/asset/JDE_left.gif?v=1&s=3781b10872dbdb403261db72c2585d845f259fc1)
1346-8138/asset/JDE_right.gif?v=1&s=a7c25c56af4096e2045f196a64e230d6768f60d0)
Original Article
You have free access to this content
Transcriptional regulatory network for psoriasis
Article first published online: 18 OCT 2012
DOI: 10.1111/1346-8138.12000
© 2012 Japanese Dermatological Association
Additional Information
How to Cite
Lu, X., Du, J., Liang, J., Zhu, X., Yang, Y. and Xu, J. (2013), Transcriptional regulatory network for psoriasis. The Journal of Dermatology, 40: 48–53. doi: 10.1111/1346-8138.12000
Conflict of interest: none.
Publication History
- Issue published online: 16 JAN 2013
- Article first published online: 18 OCT 2012
- Manuscript Accepted: 24 AUG 2012
- Manuscript Received: 26 JUN 2012
References
- 1, . Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 2003; 12: 337–345.
- 2, . Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy. Expert Rev Mol Med 2009; 11: e38.
- 3
- 4, , et al. Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R918–R930.
- 5, , , , , . Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112: 1195–1202.
- 6, , et al. Type i interferon: potential therapeutic target for psoriasis? PLoS One 2008; 3: e2737.
- 7. The kegg database. Novartis Found Symp 2002; 103: 119–128.
- 8. The transfac project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform 2008; 9: 326–332.
- 9, , , . Tred: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007; 35: D137–D140.
- 10. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: PMID: 16646809. Article3
- 11, , et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.
- 12, , . Bingo: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005; 21: 3448–3449.
- 13, . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289–300.
- 14, , et al. A systems biology approach for pathway level analysis. Genome Res 2007; 17: 1537–1545.
- 15, , , , , . C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Investig Dermatol 1991; 97: 672–678.
- 16, , et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of jun proteins. Nature 2005; 437: 369–375.
- 17, , , , . Atf3 and stress responses. Gene Expr 1999; 7: 321–336.
- 18, , et al. Comparative study of the expression of atf-3 and atf-4 genes in vessels involved into atherosclerosis process and in psoriatic skin. Bull Exp Biol Med 2011; 151: 713–716.
- 19, , et al. A subpopulation of cd163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 2010; 130: 2412–2422.
- 20, , et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2004; 11: 43–49.
- 21, , et al. Immunohistochemical localization of activated stat3 and htert protein in psoriasis vulgaris. Eur J Dermatol 2006; 16: 205–207.
- 22, , , . Abnormal epidermal barrier in the pathogenesis of psoriasis. Clin Dermatol 2012; 30: 323–328.
- 23, , et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with sta-21, a stat3 inhibitor. J Investig Dermatol 2010; 131: 108–117.
- 24, , et al. Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis. Acta Derm Venereol 2003; 83: 108–114.
- 25, , , , , . Micrornas and potential target interactions in psoriasis. J Dermatol Sci 2010; 58: 177–185.
- 26, , . Oncostatin m-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires janus kinase/stat signaling pathway. J Immunol 2001; 166: 3491.
- 27, , . Timp3 regulates mammary epithelial apoptosis with immune cell recruitment through differential tnf dependence. PLoS One 2011; 6: e26718.
- 28, . Evaluation of survivin and nf-kappab in psoriasis, an immunohistochemical study. J Cutan Pathol 2008; 35: 445–451.
- 29, , . Keratinocyte apoptosis in epidermal development and disease. J Investig Dermatol 2006; 126: 243–257.
- 30, , et al. Expression of cyclin d1 and p16 in psoriasis before and after phototherapy. Clin Exp Dermatol 2010; 35: 781–785.
- 31, , et al. Activation of ppar-α in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. FASEB J 2003; 17: 1748–1750.
- 32, , et al. Expression of antiapoptotic protein c-flip is upregulated in psoriasis epidermis. Eur J Dermatol 2009; 19: 29–33.
- 33, , , , , . Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. J Dermatol Sci 2009; 54: 168–174.
- 34, , et al. Elevated e2f1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Cancer Res 2006; 66: 11897.
- 35, , , , . Normal keratinocytes express toll-like receptors (tlrs) 1, 2 and 5: modulation of tlr expression in chronic plaque psoriasis. Br J Dermatol 2003; 148: 670–679.
- 36, , . The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Investig Dermatol 2005; 125: 1–8.
- 37, , et al. Comparison of expression of heat-shock protein 60, toll-like receptors 2 and 4, and t-cell receptor γδ in plaque and guttate psoriasis. J Cutan Pathol 2007; 34: 903–911.
- 38, , et al. Toll-like receptors are key participants in innate immune responses. Biol Res 2007; 40: 97.
- 39, , et al. The cchcr1 (hcr) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med 2007; 85: 589–601.
- 40, , , , , . Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem Biophys Res Commun 2011; 404: 62–67.
- 41, . Association of the msin3a-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. Mol Endocrinol 2006; 20: 100–113.